Literature DB >> 26476120

Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy.

Breton Roussel1, Gregory M Ouellet2, Supriya G Mohile3, William Dale4.   

Abstract

Prostate cancer (PCa) is a common medical condition in the United States, with an estimated 16% of men receiving a diagnosis during their lifetime. Although it is the second leading cause of cancer-specific deaths among men, PCa will not be the cause of death for most men who are diagnosed with it. Although there are notable improvements recently, the relative dearth of high-quality data concerning PCa screening and treatment in older men calls for a thoughtful approach to evaluating such men for screening, diagnosis, and treatment options. This article offers guidance to an approach here.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; CGA; Geriatric oncology; Geriatrics; Prostate cancer; Shared decision making

Mesh:

Substances:

Year:  2015        PMID: 26476120     DOI: 10.1016/j.cger.2015.07.004

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  10 in total

Review 1.  Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening.

Authors:  Ashwin A Kotwal; Mara A Schonberg
Journal:  Cancer J       Date:  2017 Jul/Aug       Impact factor: 3.360

2.  Mechanism and Function of Angiogenin in Prostate Cancer.

Authors:  Nil Vanli; H U Guo-Fu
Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao       Date:  2015-12-24

Review 3.  Cancer Screening in Older Adults: Individualized Decision-Making and Communication Strategies.

Authors:  Ashwin A Kotwal; Louise C Walter
Journal:  Med Clin North Am       Date:  2020-09-16       Impact factor: 5.456

4.  Oncological and functional outcomes in patients over 70 years of age treated with robotic radical prostatectomy: a propensity-matched analysis.

Authors:  Pratik M S Gurung; Bokai Wang; Stephen Hassig; Jasmine Wood; Elizabeth Ellis; Changyong Feng; Ahmed E Ghazi; Jean V Joseph
Journal:  World J Urol       Date:  2020-06-14       Impact factor: 4.226

5.  Pouchitis Associated With Pelvic Radiation for Prostate Cancer.

Authors:  Geeta Kulkarni; Xiuli Liu; Bo Shen
Journal:  ACG Case Rep J       Date:  2016-09-28

6.  Outcomes of patients older than 75 years with non-metastatic prostate cancer.

Authors:  Yoshiyasu Amiya; Yasutaka Yamada; Masahiro Sugiura; Makoto Sasaki; Takayuki Shima; Noriyuki Suzuki; Hiroomi Nakatsu; Shino Murakami; Jun Shimazaki
Journal:  Asian J Urol       Date:  2017-01-03

7.  Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker.

Authors:  Mohammad Hassan Heidari; Abolfazl Movafagh; Mohammad-Amin Abdollahifar; Shabnam Abdi; Mohamadreza Mashhoudi Barez; Hadi Azimi; Afshin Moradi; Amin Bagheri; Matineh Heidari; Jafar Hessam Mohseni; Maryam Tadayon; Hoda Mirsafian; Mahdi Ghatrehsamani
Journal:  Anat Cell Biol       Date:  2017-03-29

8.  Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients.

Authors:  Michael Brun Andersen; Dyveke Ebbesen; Jesper Thygesen; Matthijs Kruis; Finn Rasmussen
Journal:  Eur Radiol       Date:  2020-05-04       Impact factor: 5.315

9.  Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.

Authors:  Qiu-Kui Deng; Yong-Gang Lei; Ying-Li Lin; Jian-Guo Ma; Wen-Ping Li
Journal:  Med Sci Monit       Date:  2016-02-16

10.  GSTM1 and GSTT1 Polymorphisms and Susceptibility to Prostate Cancer: A Case-Control Study of the Algerian Population

Authors:  Maroua Benabdelkrim; Omar Djeffal; Hajira Berredjem
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.